Clinical Trials in Washington

Showing 7741-7760 of 9,462 trials

Effect on Weight Loss of Exenatide Versus Placebo

NCT00375492

This trial is designed to compare the effects of twice-daily exenatide and twice-daily placebo on weight loss. This trial will evaluate overweight and obese subjects with type 2 diabetes who have inadequate glycemic control with metformin, sulfonylurea, or metformin plus a sulfonylurea. Subjects will be treated with exenatide or placebo in addition to their current oral antidiabetes agent regimen and participate in a lifestyle modification program.

Type 2 Diabetes Mellitus

AstraZeneca196 participantsStarted Sep 2006

Peoria, Arizona, United States • Jacksonville, Florida, United States • Orlando, Florida, United States +7 more locations

COMPLETEDPhase 234 miles

A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients

NCT00500370

This is a multicenter study designed to compare the effect of exenatide plus a lifestyle modification plan versus placebo plus a lifestyle modification plan on weight loss in non-diabetic, obese subjects.

Obesity

AstraZeneca163 participantsStarted Jun 2007

Peoria, Arizona, United States • Tucson, Arizona, United States • Santa Ana, California, United States +13 more locations

Effect on Weight Loss of Exenatide Versus Placebo

A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients

Find Trials by Condition in Washington

Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke

Study of GC1008 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Mask Ventilation Before and After Neuromuscular Blockade

TakeCharge: Telephone Delivered Self-management Intervention for People With Multiple Sclerosis (MS)

Onsite Versus Referral Models of Primary Care for Substance Abusing Patients

A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Pravastatin for at Least 4 Weeks.

A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Atorvastatin for at Least 4 Weeks.

A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients

Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus

Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin

Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication

NET-PD LS-1 Creatine in Parkinson's Disease

Clinical Study of Aldurazyme in Patients With Mucopolysaccharidosis (MPS) I

An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes

Grass Observational Study

A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone

Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients